Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Proulx

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Langmuir : the ACS Journal of Surfaces and Colloids|November 1, 2016
Molecular Engineering of the Peptoid Nanosheet Hydrophobic CoreEllen J Robertson, Caroline Proulx, Jessica K Su, et al.
Breast Cancer Research and Treatment|April 5, 2008
Predictors of follow-up exercise behavior 6 months after a randomized trial of exercise training during breast cancer chemotherapyKerry S Courneya, Christine M Friedenreich, Robert D Reid, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2017
Adiponectin has a pivotal role in the cardioprotective effect of CP-3(iv), a selective CD36 azapeptide ligand, after transient coronary artery occlusion in miceDavid N Huynh, Valérie L Bessi, Liliane Ménard, et al.
The Analyst|June 24, 2011
Modified peptide monolayer binding His-tagged biomolecules for small ligand screening with SPR biosensorsOlivier R Bolduc, Patrick Lambert-Lanteigne, Damien Y Colin, et al.
Medicine and Science in Sports and Exercise|May 8, 2008
Predictors of supervised exercise adherence during breast cancer chemotherapyKerry S Courneya, Roanne J Segal, Karen Gelmon, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|March 19, 2008
Barriers to supervised exercise training in a randomized controlled trial of breast cancer patients receiving chemotherapyKerry S Courneya, Donald C McKenzie, Robert D Reid, et al.
Cancer|February 29, 2008
Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trialKerry S Courneya, Donald C McKenzie, John R Mackey, et al.
Atherosclerosis|July 30, 2020
Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient miceGeneviève Frégeau, Roger Sarduy, Hanan Elimam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trialKerry S Courneya, Roanne J Segal, John R Mackey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 19, 2007
Six-month follow-up of patient-rated outcomes in a randomized controlled trial of exercise training during breast cancer chemotherapyKerry S Courneya, Roanne J Segal, Karen Gelmon, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Langmuir : the ACS Journal of Surfaces and Colloids|November 1, 2016
Molecular Engineering of the Peptoid Nanosheet Hydrophobic CoreEllen J Robertson, Caroline Proulx, Jessica K Su, et al.
Breast Cancer Research and Treatment|April 5, 2008
Predictors of follow-up exercise behavior 6 months after a randomized trial of exercise training during breast cancer chemotherapyKerry S Courneya, Christine M Friedenreich, Robert D Reid, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2017
Adiponectin has a pivotal role in the cardioprotective effect of CP-3(iv), a selective CD36 azapeptide ligand, after transient coronary artery occlusion in miceDavid N Huynh, Valérie L Bessi, Liliane Ménard, et al.
The Analyst|June 24, 2011
Modified peptide monolayer binding His-tagged biomolecules for small ligand screening with SPR biosensorsOlivier R Bolduc, Patrick Lambert-Lanteigne, Damien Y Colin, et al.
Medicine and Science in Sports and Exercise|May 8, 2008
Predictors of supervised exercise adherence during breast cancer chemotherapyKerry S Courneya, Roanne J Segal, Karen Gelmon, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|March 19, 2008
Barriers to supervised exercise training in a randomized controlled trial of breast cancer patients receiving chemotherapyKerry S Courneya, Donald C McKenzie, Robert D Reid, et al.
Cancer|February 29, 2008
Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trialKerry S Courneya, Donald C McKenzie, John R Mackey, et al.
Atherosclerosis|July 30, 2020
Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient miceGeneviève Frégeau, Roger Sarduy, Hanan Elimam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trialKerry S Courneya, Roanne J Segal, John R Mackey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 19, 2007
Six-month follow-up of patient-rated outcomes in a randomized controlled trial of exercise training during breast cancer chemotherapyKerry S Courneya, Roanne J Segal, Karen Gelmon, et al.
Pageof 6